Home/Filings/4/0001437749-25-022547
4//SEC Filing

AUERBACH ALAN H 4

Accession 0001437749-25-022547

CIK 0001401667other

Filed

Jul 9, 8:00 PM ET

Accepted

Jul 10, 8:49 PM ET

Size

6.0 KB

Accession

0001437749-25-022547

Insider Transaction Report

Form 4
Period: 2025-07-08
AUERBACH ALAN H
DirectorPresident and CEO10% Owner
Transactions
  • Sale

    Common Stock

    2025-07-09$3.54/sh21,580$76,2857,180,901 total
  • Sale

    Common Stock

    2025-07-08$3.53/sh25,592$90,4177,202,481 total
Footnotes (1)
  • [F1]Adoption date of referenced 10b5-1(c) plan is: 12-17-2020

Issuer

PUMA BIOTECHNOLOGY, INC.

CIK 0001401667

Entity typeother

Related Parties

1
  • filerCIK 0001358285

Filing Metadata

Form type
4
Filed
Jul 9, 8:00 PM ET
Accepted
Jul 10, 8:49 PM ET
Size
6.0 KB